Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
US Top News and Analysis The pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023. Go to Source 10/03/2024 – 15:02 / Twitter: @hoffeldtcom